Image
Elizabeth Horn
The American Heart Journal published the BMC2 paper, “Reminders EMbedded IN PCI Reports to Optimize Discharge Diabetes Mellitus Care (REMIND-DM): Rationale, Design, and Baseline Characteristics.”
There is strong clinical evidence supporting the prescription of sodium-glucose co-transporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1RA) for positively impacting high-risk patients with type 2 diabetes and accompanying cardiovascular disease. However, prescription of these medications is underutilized. Patient encounters with their clinical care teams in the period after angiography is performed may be a key opportunity to improve implementation in high-risk patients with type 2 diabetes.
Reminders EMbedded IN PCI Reports to Optimize Discharge Diabetes Mellitus Care (REMIND-DM) is a pragmatic, prospective, cluster randomized quality improvement study in patients with type 2 diabetes undergoing angiography and was run as a BMC2 quality improvement initiative.
REMIND-DM randomized 23 participating BMC2 percutaneous coronary intervention (PCI) sites for either usual care or a quality improvement intervention consisting of a templated PCI report "reminder" of medication eligibility linked to a decision support tool.
Sites were followed for a six-month "evaluation period." The primary outcome is the new prescription of SGLT2 inhibitor or GLP-1RA among eligible patients at discharge after PCI.
To examine the effectiveness of the intervention, primary analyses will be conducted using a difference-in-difference design examining changes in new cardioprotective therapy prescription from baseline to the evaluation periods in both arms.
The REMIND-DM implementation trial has enrolled a large, high-risk population of patients with T2DM and will determine the effectiveness of a low touch QI intervention within BMC2 implemented in the period after PCI to improve timely prescription of risk-lowering therapies in high-risk patients with T2DM.
The authors are Safia Chatur, MD; Milan Seth, MS; Mary Casey, MPA; Michael P. Thompson, PhD, MPH; M. Imran Qureshi, MD; Vishal Gupta, MD; Mansoor Qureshi, MD; Bashar Samman, MD; Annemarie Forrest, MSN, MPH; Hitinder S. Gurm, MD, Devraj Sukal, MD, MSc; and Muthiah Vaduganathan, MD, MPH.
Read more at PubMed.